Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Manel Bedoui"'
Autor:
Frédérique Kuhnowski, Jean Philippe Richardet, Marie-Pierre Moles, Sébastien Mulé, Sylvie Glaisner, Manel Bedoui, Jehane Fadlallah, Julien Calderaro, Luc-Matthieu Fornecker, Pierre-Edouard Debureaux, Daniel Azoulay, Delphine Le Febvre de Nailly, Jerome Tamburini, Jehan Dupuis, Emmanuelle Tavernier, Corinne Haioun, David Sibon, Vincent Camus
Publikováno v:
Bone Marrow Transplantation. 55:1834-1836
Publikováno v:
Clinical Nuclear Medicine. 47:e140-e141
A 71-year-old woman with a history of back pain and recent weight loss presented to the emergency department with hematuria. A CT scan was performed and showed left retroperitoneal mass with left renal vein thrombus extended to the vena cava. Tumor b
Autor:
Marie Luporsi, Manel Bedoui, Frédérique Kuhnowski, Anne Vincent-Salomon, Thibaut Cassou-Mounat, Nina Jehanno
Publikováno v:
Clinical Case Reports
Key Clinical Message Infectious lymph nodes mimicking lymphoma is challenging for accurate staging. Although 18F‐FDG is a nonspecific tracer accumulating not only in tumor cells but also in inflammatory tissues, the metabolic features and uptake ki
Autor:
Samia Menif, Amel Lakhal, Yosra Ben Youssef, Raihane Ben Lakhal, Manel Bedoui, Z. Manai, Mohamed Adnène Laatiri, Tarek Ben Othmen, Hela Ghedira, Neila Ben Romdhane, Abderrahmane Khélif, Hatem Bellaaj, F. Msadek, Balkis Meddeb, Moez Elloumi
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2018, 97 (4), pp.597--604. ⟨10.1007/s00277-017-3224-2⟩
Annals of Hematology, Springer Verlag, 2018, 97 (4), pp.597--604. ⟨10.1007/s00277-017-3224-2⟩
International audience; Data are limited in developing countries regarding the clinicopathologic features and response to therapy of chronic myeloid leukemia (CML) in the era of imatinib (IM). The objective of this study is to report on the clinicoep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66925fcc39af00c0fb63c3b0c040da14
https://hal.archives-ouvertes.fr/hal-01876259
https://hal.archives-ouvertes.fr/hal-01876259
Autor:
Jean Philippe Richardet, Jehane Fadlallah, Luc Fornecker, Manel Bedoui, Sébastien Mulé, Sylvie Glaisner, David Sibon, Jerome Tamburini, Marie-Pierre Moles, Jehan Dupuis, Corinne Haouin, Pierre-Edouard Debureaux, Emmanuelle Tavernier, Daniel Azoulay, Julien Calderaro, Frédérique Kuhnowski, Hervé Tilly
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S264-S265
Autor:
Pierre-Edouard Debureaux, Delphine Le Febvre de Nailly, Emmanuelle Tavernier, Manel Bedoui, Frederique Kuhnowski, Jerome Tamburini, Luc Mathieu Fornecker, Herve Tilly, David Sibon, Marie-Pierre Moles, Sylvie Glaisner, Jean Philippe Richardet, Sebastien Mule, Julien Calderaro, Corinne Haioun, Jehan Dupuis
Publikováno v:
Blood. 132:4597-4597
Introduction ASCT is a cornerstone in lymphoma therapeutics, especially in the relapse setting. BEAM (carmustine, etoposide, cytarabine, and melphalan) is the most widely used conditioning regimen with a low rate of transplant mortality. Bendamustine
Autor:
T. Cassou Mounat, V. Huchet, A. Bando Delaunay, Manel Bedoui, A. Vincent Salomon, Marie Luporsi, Nina Jehanno
Publikováno v:
Médecine Nucléaire. 42:159
Objectif La sarcoidose est une granulomatose inflammatoire sans necrose caseeuse entrainant une atteinte multisystemique. Plusieurs cas de sarcoidoses precedees d’une maladie lymphoproliferative ont ete decrits et appeles comme etant « le syndrome
Autor:
Amel Lakhal, Raihane Ben Lakhal, Manel Bedoui, Balkis Meddeb, Yosra Ben Youssef, Hatem Bellaaj, Samia Menif, Zeineb Manai, Hela Ghedira
Publikováno v:
Blood. 122:4037-4037
Background The introduction of the first targeted tyrosine kinase inhibitor (TKI), imatinib mesylate (IM) revolutionized the therapeutic paradigm and dramatically improved outcomes of chronic myeloid leukemia(CML). Data are limited in developing coun